Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

AIMS To (i) describe an intervention implemented in response to the HIV-1 outbreak among people who inject drugs (PWIDs) in Greece (ARISTOTLE programme), (ii) assess its success in identifying and testing this population and (iii) describe socio-demographic characteristics, risk behaviours and access to treatment/prevention, estimate HIV prevalence and identify risk factors, as assessed at the first participation of PWIDs. DESIGN A 'seek, test, treat, retain' intervention employing five rounds of respondent-driven sampling. SETTING Athens, Greece (2012-13). PARTICIPANTS A total of 3320 individuals who had injected drugs in the past 12 months. INTERVENTION ARISTOTLE is an intervention that involves reaching out to high-risk, hard-to-reach PWIDs ('seek'), engaging them in HIV testing and providing information and materials to prevent HIV ('test') and initiating and maintaining anti-retroviral and opioid substitution treatment for those testing positive ('treat' and 'retain'). MEASUREMENTS Blood samples were collected for HIV testing and personal interviews were conducted. FINDINGS ARISTOTLE recruited 3320 PWIDs during the course of 13.5 months. More than half (54%) participated in multiple rounds, resulting in 7113 visits. HIV prevalence was 15.1%. At their first contact with the programme, 12.5% were on opioid substitution treatment programmes and the median number of free syringes they had received in the preceding month was 0. In the multivariable analysis, apart from injection-related variables, homelessness was a risk factor for HIV infection in male PWIDs [odds ratio (OR) yes versus no = 1.89, 95% confidence interval (CI) = 1.41, 2.52] while, in female PWIDS, the number of sexual partners (OR for > 5 versus one partner in the past year = 4.12, 95% CI = 1.93, 8.77) and history of imprisonment (OR yes versus no = 2.76, 95% CI = 1.43, 5.31) were associated with HIV. CONCLUSIONS In Athens, Greece, the ARISTOTLE intervention for identifying HIV-positive people among people who inject drugs (PWID) facilitated rapid identification of a hidden population experiencing an outbreak and provided HIV testing, counselling and linkage to care. According to ARISTOTLE data, the 2011 HIV outbreak in Athens resulted in 15% HIV infection among PWID. Risk factors for HIV among PWID included homelessness in men and history of imprisonment and number of sexual partners in women.

[1]  A. Lansky,et al.  Assessing the Assumptions of Respondent-Driven Sampling in the National HIV Behavioral Surveillance System among Injecting Drug Users , 2012, The open AIDS journal.

[2]  D. D. Des Jarlais,et al.  Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? , 2014, Annals of epidemiology.

[3]  A. Pharris,et al.  Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe? , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  A. Hatzakis,et al.  HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  R. Booth,et al.  Gender differences between predictors of HIV status among PWID in Ukraine. , 2014, Drug and alcohol dependence.

[6]  D. Heckathorn 6. Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment , 2007 .

[7]  J. Parry,et al.  High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment , 2006, AIDS.

[8]  D. Heckathorn,et al.  Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.

[9]  Hongyun Fu,et al.  Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces , 2014, Harm Reduction Journal.

[10]  H. Mills,et al.  HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia. , 2013, Drug and alcohol dependence.

[11]  R. Rothenberg,et al.  Sociometric risk networks and risk for HIV infection. , 1997, American journal of public health.

[12]  A. Hatzakis,et al.  Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study , 2013, PloS one.

[13]  K. Dolan,et al.  Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. , 1989, AIDS care.

[14]  M. Kals,et al.  Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia , 2013, AIDS and Behavior.

[15]  Dennis P. Culhane,et al.  Homelessness and HIV risk behaviors among injection drug users , 2004, Journal of Urban Health.

[16]  R. Écochard,et al.  Age at Which HIV Infection Can Be Detected in Infants: Place of the Yakovlev Model , 2006, Journal of acquired immune deficiency syndromes.

[17]  Don C Des Jarlais,et al.  Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. , 2002, Journal of acquired immune deficiency syndromes.

[18]  A. Hatzakis,et al.  HIV epidemiology in Greece. , 2008, Future microbiology.

[19]  R. Garfein,et al.  HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010 , 2012, The American journal of drug and alcohol abuse.

[20]  Patrick S Sullivan,et al.  Behavioral Surveillance among People at Risk for HIV Infection in the U.S.: The National HIV Behavioral Surveillance System , 2007, Public health reports.

[21]  A. Pharris,et al.  Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  A. Uusküla,et al.  The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[23]  J. Desenclos,et al.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. , 1993, AIDS.

[24]  A. Hatzakis,et al.  Managing opioid dependence treatment and controlling for HIV incidence among injecting drug users in Greece: a case study of optimism in the face of adversity. , 2013, Addiction.

[25]  N. Nurjannah,et al.  HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs , 2012, Harm Reduction Journal.

[26]  M. Zunzunegui,et al.  Women, drugs and HIV/AIDS: results of a multicentre European study. , 2000, International journal of epidemiology.

[27]  Matthew J. Salganik Variance Estimation, Design Effects, and Sample Size Calculations for Respondent-Driven Sampling , 2006, Journal of Urban Health.

[28]  G. Rutherford,et al.  Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. , 2014, The International journal on drug policy.

[29]  D. Raoult,et al.  Infections in the homeless. , 2001, The Lancet. Infectious diseases.

[30]  R. Garfein,et al.  Housing Status and Associated Differences in HIV Risk Behaviors Among Young Injection Drug Users (IDUs) , 2007, AIDS and Behavior.

[31]  Matthew Hickman,et al.  Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia , 2002, AIDS.

[32]  M. Zunzunegui,et al.  Determinants of HIV prevalence amongst female IDU in Madrid , 2004, European Journal of Epidemiology.

[33]  D. D. Jarlais,et al.  Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. , 2015, American journal of public health.

[34]  K. Dolan,et al.  Life-style factors and social circumstances of syringe sharing in injecting drug users. , 1992, British journal of addiction.

[35]  Mohsen Malekinejad,et al.  Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: A Systematic Review , 2008, AIDS and Behavior.

[36]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[37]  E. Regidor,et al.  Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. , 2012, Addiction.

[38]  D. Celentano,et al.  The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. , 2013, Drug and alcohol dependence.

[39]  Douglas D. Heckathorn,et al.  Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hi , 2002 .

[40]  O. Levina,et al.  Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study , 2013, BMJ Open.

[41]  Julio S. G. Montaner,et al.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.